These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38873705)

  • 1. Sodium-Glucose Cotransporter 2 Therapy for Acute Organ Dysfunction in Critically Ill Patients.
    Gómez H; Derde LPG
    JAMA; 2024 Jun; ():. PubMed ID: 38873705
    [No Abstract]   [Full Text] [Related]  

  • 2. Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical Trial.
    Tavares CAM; Azevedo LCP; Rea-Neto Á; Campos NS; Amendola CP; Kozesinski-Nakatani AC; David-João PG; Lobo SM; Filiponi TC; Almeida GMB; Bergo RR; Guimarães-Júnior MRR; Figueiredo RC; Castro JR; Schuler CJ; Westphal GA; Carioca ACR; Monfradini F; Nieri J; Neves FMO; Paulo JA; Albuquerque CSN; Silva MCR; Kosiborod MN; Pereira AJ; Damiani LP; Corrêa TD; Serpa-Neto A; Berwanger O; Zampieri FG;
    JAMA; 2024 Jun; ():. PubMed ID: 38873723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapagliflozin in patients with critical illness: rationale and design of the DEFENDER study.
    Tavares CAM; Azevedo LCP; Rea-Neto Á; Campos NS; Amendola CP; Bergo RR; Kozesinski-Nakatani AC; David-João PG; Westphal GA; Guimarães Júnior MRR; Lobo SMA; Tavares MS; Dracoulakis MDA; Souza GM; Almeida GMB; Gebara OCE; Tomba PO; Albuquerque CSN; Silva MCR; Pereira AJ; Damiani LP; Corrêa TD; Serpa-Neto A; Berwanger O; Zampieri FG
    Crit Care Sci; 2023; 35(3):256-265. PubMed ID: 38133155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: Sodium-glucose cotransporter 2 inhibitors induce left ventricular reverse remodeling in anthracycline-related cardiac dysfunction-a case series.
    Giangiacomi F; Faggiano A; Cardinale D; Rossi FG; Pollina A; Gherbesi E; Gnan E; Carugo S; Vicenzi M
    Front Cardiovasc Med; 2023; 10():1250185. PubMed ID: 37674808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients.
    Koch A; Gressner OA; Sanson E; Tacke F; Trautwein C
    Crit Care; 2009; 13(3):R95. PubMed ID: 19545363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy in Critically Ill Patients With Hemodynamic Worsening.
    Wang T; Yi L; Zhang H; Wang T; Xi J; Zeng L; He J; Zhang Z; Ma P
    Front Med (Lausanne); 2021; 8():665907. PubMed ID: 34307402
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute gastrointestinal injury in critically ill patients with COVID-19 in Wuhan, China.
    Sun JK; Liu Y; Zou L; Zhang WH; Li JJ; Wang Y; Kan XH; Chen JD; Shi QK; Yuan ST
    World J Gastroenterol; 2020 Oct; 26(39):6087-6097. PubMed ID: 33132657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stress gastrointestinal bleeding in critically ill patients and its effect on the prognosis].
    Chai WZ; Wang XT; Chen XK; Zhang Q; Liu DW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):449-51. PubMed ID: 19742331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities in glucose homeostasis in critically ill children.
    Bhutia TD; Lodha R; Kabra SK
    Pediatr Crit Care Med; 2013 Jan; 14(1):e16-25. PubMed ID: 23249786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of preoperative sodium-glucose cotransporter 2 inhibitors on the incidence of perioperative metabolic acidosis: A retrospective cohort study.
    Iwasaki Y; Sasabuchi Y; Horikita S; Furukawa T; Shiotsuka J; Lefor AK; Sanui M
    BMC Endocr Disord; 2022 Aug; 22(1):209. PubMed ID: 35987618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of sodium-glucose cotransporter 2 inhibitors during the perioperative period: A retrospective comparative study.
    Ge V; Subramaniam A; Banakh I; Wang WC; Tiruvoipati R
    J Perioper Pract; 2021 Oct; 31(10):391-398. PubMed ID: 32894998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin therapy is not associated with improved clinical outcomes in critically ill infants with stress hyperglycemia.
    Wen F; Zhang Y; Lin C; Deng M; Zhang J; Zhang J
    Exp Ther Med; 2019 Jul; 18(1):397-403. PubMed ID: 31258678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium-Glucose Cotransporter Inhibitors for the Treatment of Type 1 Diabetes Mellitus.
    Li N; Chen R; Liu K
    Clin Drug Investig; 2020 Nov; 40(11):991-1000. PubMed ID: 32725362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the place of sodium-glucose cotransporter-2 inhibitors and dual sodium-glucose cotransporter-1 and dual sodium-glucose cotransporter-2 inhibitors in heart failure therapy: a systematic review of the literature.
    McKenzie T; Hale GM; Miner A; Colón Colón J; Evins G; Wade J
    Heart Fail Rev; 2024 Mar; 29(2):549-558. PubMed ID: 38300379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports.
    Juneja D; Nasa P; Jain R; Singh O
    World J Diabetes; 2023 Aug; 14(8):1314-1322. PubMed ID: 37664476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of early combined lactate and glucose levels with subsequent renal and liver dysfunction and hospital mortality in critically ill patients.
    Freire Jorge P; Wieringa N; de Felice E; van der Horst ICC; Oude Lansink A; Nijsten MW
    Crit Care; 2017 Aug; 21(1):218. PubMed ID: 28826408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What Have We Learned so Far From the Use of Sodium-Glucose Cotransporter 2 Inhibitors in Clinical Practice?
    Rossing P; Persson F
    Adv Chronic Kidney Dis; 2021 Jul; 28(4):290-297. PubMed ID: 34922685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Multiple Organ Dysfunction and Renal Recovery in Critically Ill Children and Young Adults Receiving Continuous Renal Replacement Therapy.
    Thadani S; Fuhrman D; Hanson C; Park HJ; Angelo J; Srivaths P; Typpo K; Bell MJ; Gist KM; Carcillo J; Akcan-Arikan A
    Crit Care Explor; 2024 May; 6(5):e1084. PubMed ID: 38709083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Serum Tenascin-C Predicts Mortality in Critically Ill Patients With Multiple Organ Dysfunction.
    Xu Y; Li N; Gao J; Shang D; Zhang M; Mao X; Chen R; Zheng J; Shan Y; Chen M; Xie Q; Hao CM
    Front Med (Lausanne); 2021; 8():759273. PubMed ID: 34901073
    [No Abstract]   [Full Text] [Related]  

  • 20. Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors-protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial).
    Al-Ozairi E; Narula K; Miras AD; Taghadom E; Samad AE; Al Kandari J; Alyosef A; Mashankar A; Al-Najim W; le Roux CW
    Trials; 2024 Feb; 25(1):129. PubMed ID: 38365744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.